Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switching to aromatase inhibitors in early breast cancer.
Boccardo F, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3. Lancet. 2007. PMID: 17307082 No abstract available.
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Boccardo F, Rubagotti A, Bruzzi P, Cappellini M, Isola G, Nenci I, Piffanelli A, Scanni A, Sismondi P, Santi L, et al. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 1990 Aug;8(8):1310-20. doi: 10.1200/JCO.1990.8.8.1310. J Clin Oncol. 1990. PMID: 2199618 Clinical Trial.
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study.
Boccardo F, Rubagotti A, Perrotta A, Amoroso D, Balestrero M, De Matteis A, Zola P, Sismondi P, Francini G, Petrioli R, et al. Boccardo F, et al. Among authors: rubagotti a. Ann Oncol. 1994 Apr;5(4):337-42. doi: 10.1093/oxfordjournals.annonc.a058837. Ann Oncol. 1994. PMID: 8075030 Free article. Clinical Trial.
Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group.
Boccardo F, Pace M, Rubagotti A, Guarneri D, Decensi A, Oneto F, Martorana G, Giuliani L, Selvaggi F, Battaglia M, et al. Boccardo F, et al. Among authors: rubagotti a. Eur J Cancer. 1993;29A(8):1088-93. doi: 10.1016/s0959-8049(05)80293-x. Eur J Cancer. 1993. PMID: 8518017 Clinical Trial.
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.
Conte PF, Bruzzone M, Carnino F, Gadducci A, Algeri R, Bellini A, Boccardo F, Brunetti I, Catsafados E, Chiara S, Foglia G, Gallo L, Iskra L, Mammoliti S, Parodi G, Ragni N, Rosso R, Rugiati S, Rubagotti A. Conte PF, et al. Among authors: rubagotti a. J Clin Oncol. 1996 Feb;14(2):351-6. doi: 10.1200/JCO.1996.14.2.351. J Clin Oncol. 1996. PMID: 8636743 Clinical Trial.
121 results